Everolimus in combination with rituximab induces complete responses in heavily pretreated diffuse large B-cell lymphoma
Jeffrey A. Barnes(Harvard University), Jeremy S. Abramson(Massachusetts General Hospital)
Cited by 67
Related Papers
Non-Hodgkin’s Lymphomas
|Journal of the National Comprehensive Cancer Network|2010|329
Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity
|Blood|2016|289
NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016
|Journal of the National Comprehensive Cancer Network|2016|141